In an interaction with YourStory, Siddharth Shah, Co-founder and CEO, PharmEasy, speaks about the Thyrocare deal, raising capital, and the startup’s IPO

The month of June has been a mad rush for PharmEasy co-founders Siddharth Shah, Dharmil Sheth, Dhaval Shah, Harsh Parekh, and Hardik Dedhia. 

API Holdings, the parent company of healthtech unicorn PharmEasy, acquired 66.1 percent stake in Thyrocare from Dr A Velumani and affiliates at a price of Rs 1,300 per share, aggregating to Rs 4,546 crore.

Like most startups, PharmEasy has experienced several highs and lows in the past six years, but sealing the Thyrocare deal in such a short span of time has been one of the biggest challenges for the team.